The European Union’s AI Act & its Impact on Medical Devices

The AI Act (AIA) is the EU's first attempt to create a comprehensive AI regulatory framework and aims to ensure the protection of fundamental rights in this field. AI applications used in healthcare are often 'medical devices' and are thus regulated under the EU Medical Devices Regulation (MDR).

The AI Act (AIA) is the EU's first attempt to create a comprehensive AI regulatory framework and aims to ensure the protection of fundamental rights in this field. AI applications used in healthcare are often 'medical devices' and are thus regulated under the EU Medical Devices Regulation (MDR).
April 2, 2024

The European Union’s AI Act is set to revolutionize the landscape of AI applications in the medical field, with profound implications for Medical Devices and In-vitro Diagnostic Medical Devices (IVD). Let’s dive into the key highlights and its impact on healthcare:

 

  • EU AI Act Overview: Recently approved by the European Parliament, the AI Act establishes a robust regulatory framework for AI systems, prioritizing alignment with EU values and ensuring a unified market for AI applications across the region.
  • High-Risk AI in Healthcare: The Act categorizes AI used in healthcare, especially within Medical Devices, as high-risk. This includes AI utilized for diagnosing, monitoring, and treatment guidance. Such AI must undergo stringent conformity assessments to meet EU standards.
  • Regulatory Demands: High-risk AI providers face comprehensive regulatory demands, including data governance, technical documentation, quality management systems, and oversight requirements, among others. Compliance is crucial to avoid penalties, reaching up to 7% of global turnover for non-compliance.
  • Certification and Enforcement Timeline: Certification processes, including the AI CE Marking, will be crucial for compliance. The Act acknowledges the evolving nature of AI and allows for pre-agreed changes without re-assessment. Enforcement will be rolled out in stages over the coming years.
  • Organizational Impact and Compliance: Organizations operating in the healthcare sector are urged to establish robust AI governance and compliance strategies, incorporating the requirements of the AI Act and broader ethical AI principles. Dedicated AI regulatory affairs roles may become essential to navigate these regulations effectively.

 

The EU’s AI Act represents a significant milestone in shaping the future of AI in healthcare, ensuring safety, transparency, and adherence to ethical standards. Have a look at the document we have prepared with all impacts in detail: AI Act Medical Devices

Stay tuned for further updates and guidance as we navigate this transformative regulatory landscape together!

If you need solutions for your Medical Devices, contact us at: [email protected]

 

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting